MEDIFAST (MED)
(Delayed Data from NYSE)
$16.92 USD
-0.22 (-1.28%)
Updated Dec 20, 2024 04:00 PM ET
After-Market: $17.03 +0.11 (0.65%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Medifast (MED) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Downside to Average Price Target |
---|---|---|---|
$16.50 | $17.00 | $16.00 | -3.73% |
Price Target
Based on short-term price targets offered by two analysts, the average price target for Medifast comes to $16.50. The forecasts range from a low of $16.00 to a high of $17.00. The average price target represents a decline of 3.73% from the last closing price of $17.14.
Analyst Price Targets (2 )
Find the top stocks with the greatest price target potential and Zacks Rank of 1 or 2
Broker Rating
Medifast currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by two brokerage firms. The current ABR compares to an ABR of 3.00 a month ago based on two recommendations.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 1 | 1 |
ABR | 3.00 | 3.00 | 3.00 | 4.00 | 4.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
11/5/2024 | D.A. Davidson | Linda B Weiser | Strong Sell | Hold |
11/1/2024 | Stephens | Jim Salera | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 3.00 |
ABR (Last week) | 3.00 |
# of Recs in ABR | 2 |
Average Target Price | $16.50 |
LT Growth Rate | NA |
Industry | Food - Miscellaneous |
Industry Rank by ABR | 138 of 251 |
Current Quarter EPS Est: | -0.27 |
MED FAQs
MEDIFAST INC (MED) currently has an average brokerage recommendation (ABR) of 3.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 2 brokerage firms.
The average price target for MEDIFAST INC (MED) is $16.50. The current on short-term price targets is based on 3 reports.
The forecasts for MEDIFAST INC (MED) range from a low of $16 to a high of $17. The average price target represents a decline of $2.48 from the last closing price of $16.92.
The current DOWNSIDE for MEDIFAST INC (MED) is 2.48%
Based on short-term price targets offered by two analysts, the average price target for Medifast comes to $16.50. The forecasts range from a low of $16.00 to a high of $17.00. The average price target represents a decline of 3.73% from the last closing price of $17.14.